These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12185585)
1. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585 [TBL] [Abstract][Full Text] [Related]
2. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
3. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519 [TBL] [Abstract][Full Text] [Related]
4. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]. Brabletz T; Jung A; Dag S; Reu S; Kirchner T Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438 [TBL] [Abstract][Full Text] [Related]
5. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787 [TBL] [Abstract][Full Text] [Related]
6. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin. Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053 [TBL] [Abstract][Full Text] [Related]
10. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Dihlmann S; Siermann A; von Knebel Doeberitz M Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
13. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. Hlubek F; Spaderna S; Jung A; Kirchner T; Brabletz T Int J Cancer; 2004 Jan; 108(2):321-6. PubMed ID: 14639622 [TBL] [Abstract][Full Text] [Related]
14. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Sparks AB; Morin PJ; Vogelstein B; Kinzler KW Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795 [TBL] [Abstract][Full Text] [Related]
16. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505 [TBL] [Abstract][Full Text] [Related]
17. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774 [TBL] [Abstract][Full Text] [Related]
18. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Gustavson MD; Crawford HC; Fingleton B; Matrisian LM Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508 [TBL] [Abstract][Full Text] [Related]
19. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis. Bhatia N; Spiegelman VS Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534 [TBL] [Abstract][Full Text] [Related]
20. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]